These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 8596187)

  • 1. Sterilisation of Babesia canis infections by imidocarb alone or in combination with diminazene.
    Penzhorn BL; Lewis BD; de Waal DT; López Rebollar LM
    J S Afr Vet Assoc; 1995 Sep; 66(3):157-9. PubMed ID: 8596187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the efficacy of isometamidium, amicarbalide and diminazene against Babesia canis in dogs and the effect on subsequent immunity.
    Stewart CG
    J S Afr Vet Assoc; 1983 Mar; 54(1):47-51. PubMed ID: 6631891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in selected subpopulations of lymphocytes in dogs infected with Babesia canis treated with imidocarb.
    Adaszek Ł; Jarosz Ł; Kalinowski M; Staniec M; Grądzki Z; Salmons B; Winiarczyk S
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2015; 43(2):94-100. PubMed ID: 25771779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in haematocrit after treatment of uncomplicated canine babesiosis: a comparison between diminazene and trypan blue, and an evaluation of the influence of parasitaemia.
    Jacobson LS; Reyers F; Berry WL; Viljoen E
    J S Afr Vet Assoc; 1996 Jun; 67(2):77-82. PubMed ID: 8765067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of imidocarb dipropionate to eliminate Hepatozoon canis in naturally infected dogs based on parasitological and molecular evaluation methods.
    Sasanelli M; Paradies P; Greco B; Eyal O; Zaza V; Baneth G
    Vet Parasitol; 2010 Aug; 171(3-4):194-9. PubMed ID: 20444549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humoral immunity and reinfection resistance in dogs experimentally inoculated with Babesia canis and either treated or untreated with imidocarb dipropionate.
    Brandão LP; Hagiwara MK; Myiashiro SI
    Vet Parasitol; 2003 Jun; 114(4):253-65. PubMed ID: 12809752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy against babesiosis.
    Vial HJ; Gorenflot A
    Vet Parasitol; 2006 May; 138(1-2):147-60. PubMed ID: 16504402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological changes and effect of imidocarb therapy in dogs experimentally infected with Babesia canis.
    Máthé A; Vörös K; Németh T; Biksi I; Hetyey C; Manczur F; Tekes L
    Acta Vet Hung; 2006 Mar; 54(1):19-33. PubMed ID: 16613023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of a large unnamed Babesia piroplasm originally identified in dogs in North Carolina in a dog with no history of travel to that state.
    Holman PJ; Backlund BB; Wilcox AL; Stone R; Stricklin AL; Bardin KE
    J Am Vet Med Assoc; 2009 Oct; 235(7):851-4. PubMed ID: 19793016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of atovaquone against Babesia microti in the Mongolian gerbil, Meriones unguiculatus.
    Gray JS; Pudney M
    J Parasitol; 1999 Aug; 85(4):723-8. PubMed ID: 10461956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic implications of Babesia canis infection in dogs.
    Moore DJ
    J S Afr Vet Assoc; 1979 Dec; 50(4):346-52. PubMed ID: 553976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy, safety and tolerance of imidocarb dipropionate versus atovaquone or buparvaquone plus azithromycin used to treat sick dogs naturally infected with the Babesia microti-like piroplasm.
    Checa R; Montoya A; Ortega N; González-Fraga JL; Bartolomé A; Gálvez R; Marino V; Miró G
    Parasit Vectors; 2017 Mar; 10(1):145. PubMed ID: 28292316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autochthonous babesiosis in dogs in the Netherlands?].
    Houwers DJ; Teske E; Jongejan F
    Tijdschr Diergeneeskd; 2004 May; 129(9):310. PubMed ID: 15156658
    [No Abstract]   [Full Text] [Related]  

  • 14. Autochthonous canine babesiosis in The Netherlands.
    Matjila TP; Nijhof AM; Taoufik A; Houwers D; Teske E; Penzhorn BL; de Lange T; Jongejan F
    Vet Parasitol; 2005 Jul; 131(1-2):23-9. PubMed ID: 15923085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of an acute phase response in dogs naturally infected with Babesia canis.
    Matijatko V; Mrljak V; Kis I; Kucer N; Forsek J; Zivicnjak T; Romić Z; Simec Z; Ceron JJ
    Vet Parasitol; 2007 Mar; 144(3-4):242-50. PubMed ID: 17116368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First case of babesiosis caused by Babesia canis canis in a dog from Norway.
    Øines Ø; Storli K; Brun-Hansen H
    Vet Parasitol; 2010 Aug; 171(3-4):350-3. PubMed ID: 20378251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiprotozoal treatment of canine babesiosis.
    Baneth G
    Vet Parasitol; 2018 Apr; 254():58-63. PubMed ID: 29657012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Babesia canis and Babesia rossi co-infection in an untraveled Nigerian dog.
    Kamani J; Sannusi A; Dogo AG; Tanko JT; Egwu KO; Tafarki AE; Ogo IN; Kemza S; Onovoh E; Shamaki D; Lombin LH; Catto V; Birkenheuer AJ
    Vet Parasitol; 2010 Oct; 173(3-4):334-5. PubMed ID: 20705395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Babesia and the pet travel scheme.
    Perkins SC
    Vet Rec; 2000 Oct; 147(16):460. PubMed ID: 11079446
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical and serological observations on experimental infections with Babesia canis and its diagnosis using the IFAT.
    Vercammen F; De Deken R; Maes L
    Parasite; 1995 Dec; 2(4):407-10. PubMed ID: 8745740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.